Institute for Wealth Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-1,890
Closed -$100K – 635
2026
Q2
$100K Buy
+1,890
New +$84.3K 0.01% 683

Other funds holding BBC

Institute for Wealth Management's BBC Position: Q3 2026 in Review

Institute for Wealth Management sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q3 2026, closing a stake of 1,890 shares — an estimated $100K sold.

Institute for Wealth Management first reported a position in BBC in Q2 2026 and held it in 1 quarter. The position peaked at $100K in Q2 2026. 17 funds tracked by Wall St. Rank hold BBC as of Q3 2026.

  • Institute for Wealth Management reported no remaining Virtus Biotech Clinical Trials ETF position as of Q3 2026 after selling out during the quarter.
  • Institute for Wealth Management sold 1,890 Virtus Biotech Clinical Trials ETF shares in Q3 2026, an estimated $100K.
  • Institute for Wealth Management first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2026 and held it in 1 quarter.
  • Institute for Wealth Management's Virtus Biotech Clinical Trials ETF position peaked at $100K in Q2 2026.
  • 17 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2026.

Based on Institute for Wealth Management's 13F filing for Q3 2026, filed 6 Nov 2026.